Myovant Sciences Ltd. (34) | Investor Rights Agreements (1)

Recent Contracts

Investor Rights Agreement, dated as of December 27, 2019, by and among the Registrant, Sumitovant Biopharma Ltd. and Sumitomo Dainippon Pharma Co., Ltd (Filed With SEC on February 10, 2020)